These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 20424115

  • 1. Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells.
    Ameziane-El-Hassani R, Boufraqech M, Lagente-Chevallier O, Weyemi U, Talbot M, Métivier D, Courtin F, Bidart JM, El Mzibri M, Schlumberger M, Dupuy C.
    Cancer Res; 2010 May 15; 70(10):4123-32. PubMed ID: 20424115
    [Abstract] [Full Text] [Related]

  • 2. Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation.
    Caudill CM, Zhu Z, Ciampi R, Stringer JR, Nikiforov YE.
    J Clin Endocrinol Metab; 2005 Apr 15; 90(4):2364-9. PubMed ID: 15671095
    [Abstract] [Full Text] [Related]

  • 3. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M, Zitzelsberger H, Tallini G.
    J Clin Endocrinol Metab; 2006 Jun 15; 91(6):2414-23. PubMed ID: 16595592
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features.
    Durand S, Ferraro-Peyret C, Joufre M, Chave A, Borson-Chazot F, Selmi-Ruby S, Rousset B.
    Endocr Relat Cancer; 2009 Jun 15; 16(2):467-81. PubMed ID: 19208736
    [Abstract] [Full Text] [Related]

  • 7. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).
    Nakazawa T, Kondo T, Kobayashi Y, Takamura N, Murata S, Kameyama K, Muramatsu A, Ito K, Kobayashi M, Katoh R.
    Cancer; 2005 Sep 01; 104(5):943-51. PubMed ID: 16015630
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
    Mizuno T, Iwamoto KS, Kyoizumi S, Nagamura H, Shinohara T, Koyama K, Seyama T, Hamatani K.
    Oncogene; 2000 Jan 20; 19(3):438-43. PubMed ID: 10656692
    [Abstract] [Full Text] [Related]

  • 10. Low dose irradiation of thyroid cells reveals a unique transcriptomic and epigenetic signature in RET/PTC-positive cells.
    Abou-El-Ardat K, Monsieurs P, Anastasov N, Atkinson M, Derradji H, De Meyer T, Bekaert S, Van Criekinge W, Baatout S.
    Mutat Res; 2012 Mar 01; 731(1-2):27-40. PubMed ID: 22027090
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of silencing RET/PTC1 junction oncogene in human papillary thyroid carcinoma cells.
    Gilbert-Sirieix M, Ripoche H, Malvy C, Massaad-Massade L.
    Thyroid; 2010 Oct 01; 20(10):1053-65. PubMed ID: 20615140
    [Abstract] [Full Text] [Related]

  • 14. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
    Sheils OM, O'Leary JJ, Sweeney EC.
    J Pathol; 2000 Sep 01; 192(1):32-6. PubMed ID: 10951397
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation.
    Buckwalter TL, Venkateswaran A, Lavender M, La Perle KM, Cho JY, Robinson ML, Jhiang SM.
    Oncogene; 2002 Nov 21; 21(53):8166-72. PubMed ID: 12444552
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus.
    Pisarchik AV, Ermak G, Fomicheva V, Kartel NA, Figge J.
    Thyroid; 1998 Feb 21; 8(2):133-9. PubMed ID: 9510121
    [Abstract] [Full Text] [Related]

  • 19. Formation of carcinogenic chromosomal rearrangements in human thyroid cells after induction of double-strand DNA breaks by restriction endonucleases.
    Evdokimova V, Gandhi M, Rayapureddi J, Stringer JR, Nikiforov YE.
    Endocr Relat Cancer; 2012 Jun 21; 19(3):271-81. PubMed ID: 22323563
    [Abstract] [Full Text] [Related]

  • 20. Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors.
    Henderson YC, Fredrick MJ, Clayman GL.
    Arch Otolaryngol Head Neck Surg; 2007 Aug 21; 133(8):810-5. PubMed ID: 17709622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.